. A Munich court has granted AstraZeneca’s petition to set aside a German Arbitration Institute (DIS) award worth US$46.4 million in favor of the former owners of a cancer diagnostics start-up.
. A Munich court has granted AstraZeneca’s petition to set aside a German Arbitration Institute (DIS) award worth US$46.4 million in favor of the former owners of a cancer diagnostics start-up.